MedTrace Logo

Quality of Life Associated With a Low-Risk Screening Program for Ovarian Cancer

NCT00511641 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1342

Last updated 2019-06-24

No results posted yet for this study

Summary

The goal of this research study is to learn more about how women feel about an ovarian cancer screening program that involves getting a blood test to measure CA 125 levels. This includes finding out about women's quality of life and whether they are concerned or worried about their risk of developing cancer. This study also seeks to find out whether elevated CA 125 levels affect participants in terms of cancer worries or concerns.

Conditions

Interventions

BEHAVIORAL

Questionnaire

Questionnaires lasting up to 30 minutes.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Diane C. Bodurka, MD · M.D. Anderson Cancer Center

Eligibility

Min Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-02-12
Primary Completion
2020-02-29
Completion
2021-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00511641 on ClinicalTrials.gov